Appointment as Corporate Broker of Solvonis Therapeutics plc - Singer Capital Markets

Home Appointment as Corporate Broker of Solvonis Therapeutics plc

May 2025 - Deal Announcements

Appointment as Corporate Broker of Solvonis Therapeutics plc

Singer Capital Markets is delighted to have been appointed as Corporate Broker to Solvonis Therapeutics plc with immediate effect.

About Solvonis Therapeutics plc

Solvonis Therapeutics plc is a clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders.

Ticker: SVNS
Market Cap: £8 million*
Website: Click here

*As of 28^th May 2025

Account Team

Investment Banking

Philip Davies
Managing Director, Investment Banking
Email | Call

Tom Salvesen
Head of Corporate Broking
Email | Call

Patrick Weaver
Analyst, Investment Banking
Email | Call

Research

Karl Keegan
Head of Research
Email | Call

Jonathan Dighe
Equity Sales
Email | Call

Investor Relations

Lisa Alarcon
Investor Relations
Email | Call

Keep Reading …

Appointment as Nominated Advisor and Broker to TheraCryf plc

Singer Capital Markets is delighted to have been appointed as Nominated Advisor and Sole Broker to SkinBioTherapeutics plc with immediate effect.

Deal Announcements

Appointment as Corporate Broker of HSS Hire Group plc

Singer Capital Markets is delighted to have been appointed as Corporate Broker to HSS Hire Group plc with immediate effect.

Deal Announcements

Appointment as Corporate Broker of Solvonis Therapeutics plc

Singer Capital Markets is delighted to have been appointed as Corporate Broker to Solvonis Therapeutics plc with immediate effect.

Deal Announcements

Let’s Talk

If you’re looking for more information about any of our services, or if you can’t find what you’re looking for directly on our site, please do not hesitate to contact us.